UroGen Pharma URGN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $875.31M.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's market capitalization?
- UroGen Pharma (URGN) reported market capitalization of $875.31M in Q1 2026.
- How has UroGen Pharma's market capitalization changed year-over-year?
- UroGen Pharma's market capitalization increased by 71.7% year-over-year, from $509.8M to $875.31M.
- What is the long-term trend for UroGen Pharma's market capitalization?
- Over 5 years (2020 to 2025), UroGen Pharma's market capitalization has grown at a 22.1% compound annual growth rate (CAGR), from $404.01M to $1.1B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.